Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
March 13 2017 - 4:37PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-37358
COLUCID PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
222 Third Street
Cambridge, MA 02142
(857) 285-6495
(Address,
including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, $0.001
par value per share
(Title of each class of securities covered by this Form)
None
(Title of all other
classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to
designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
Rule 12g-4(a)(2)
|
|
☐
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
Rule 15d-6
|
|
☐
|
Approximate number of holders of record as of the certification or notice date:
One
Pursuant to the requirements of the Securities Exchange Act of 1934, CoLucid Pharmaceuticals, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
CoLucid Pharmaceuticals, Inc.
|
|
|
|
|
Date: March 13, 2017
|
|
|
|
By:
|
|
/s/ Darren J. Carroll
|
|
|
|
|
Name:
|
|
Darren J. Carroll
|
|
|
|
|
Title:
|
|
President
|
COLUCID PHARMACEUTICALS, INC. (NASDAQ:CLCD)
Historical Stock Chart
From Mar 2024 to Apr 2024
COLUCID PHARMACEUTICALS, INC. (NASDAQ:CLCD)
Historical Stock Chart
From Apr 2023 to Apr 2024